Monoclonal antibody therapy for solid tumors

This publication has 105 references indexed in Scilit:

• Chimaeric anti‐interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose‐escalating study
  British Journal of Haematology, 1998
• Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases
  Lung Cancer, 1996
• Overexpression of her-2/neu in human prostate cancer and benign hyperplasia
  Cancer Letters, 1996
• Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
  Cancer Immunology, Immunotherapy, 1995
• CD20: a regulator of cell-cycle progression of B lymphocytes
  Immunology Today, 1994
• Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
  Cancer Immunology, Immunotherapy, 1993
• Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
  Journal of Clinical Immunology, 1991
• Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids
  Cancer Immunology, Immunotherapy, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Replacing the complementarity-determining regions in a human antibody with those from a mouse
  Nature, 1986